Expiratory Muscle Strength Training for Hypernasal Speech in Children

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-17
SponsorNoel Jabbour

About this trial

When the soft palate does not move enough because of a cleft palate or for unknown reasons, this can lead to a speech difference called velopharyngeal insufficiency. The purpose of this research study is to test if soft palate exercises using a hand help breathing device will help improve the ability of the soft palate to close the area between the throat and nose and help improve speech.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Score of 2 or greater on the nasality/resonance domain of the Pittsburgh Weighted Speech Scale

Ages 5-17 years

Disqualifiers

CAPS-A-AM hypernasality score <2

Previous speech surgery (e.g. palatoplasty or pharyngeal flap for speech)

Speech surgery scheduled within the next 56 days

Unable or unwilling to perform the tests and exercises outlined in the study

Trial design

Design model

Sequential

Treatments tested in this trial

  • Expiratory Muscle Strength Training

    Device

    At visit 1, participants will be block randomized based on PWSS score (5-6 or 7+) to Expiratory Muscle Strength Training (EMST) for 6 to 8 weeks or no exercises. Participants in the EMST-150 group will perform 5 sets of 5 resistive expirations once a day with a 10-15 second rest between each repetition and a 1-2 minute rest between each set of 5 repetitions.

  • Maintenance Training

    Device

    At visit 2, participants with improved (decreased) CAPS-A hypernasality rating of 1 or more points, for whom the family and/or surgeon is not currently considering surgical intervention for VPI, will be further randomized to continue "maintenance" EMST exercises or no exercises for 6 months. Participants in the "maintenance" group will complete 3-5 sessions exercise sessions each week (rather than daily training), with 2 sets of 5 resistive expirations (rather than 5 sets)

Treatment groups

30 Participants
are divided into 3 treatment groups
Group A: Expiratory Muscle Strength Training + No Maintenance TrainingExperimental treatment 1 intervention
Group B: Expiratory Muscle Strength Training + Maintenance TrainingExperimental treatment 2 interventions
Group C: Expiratory Muscle Strength TrainingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in nasalance scores after 6-8 weeks of exercises compared with baseline

Percent change in nasalance measured during nasometry

Time frame
Baseline and 6-8 weeks
2

Change in perceptual speech symptoms of velopharyngeal dysfunction following 6-8 weeks of exercises compared with baseline

Perceptual symptoms of velopharyngeal incompetence measured using the CAPS-A-AM hypernasality score, on a scale of 0-4. 0 indicates nasality that is normal for the region, 1 (borderline/minimal) suggests a minimal or inconsistent increase in nasal resonance, 2 (mild) implies hypernasality that is evident on vowels with a high tongue posture, 3 (moderate) indicates hypernasality that is perceived across all vowels, and 4 (severe) signifies that hypernasality is evident in voiced consonants and all vowels.

Time frame
Baseline and 6-8 weeks
3

Change in oral pressure following 6-8 weeks of exercises compared with baseline

Percent change in oral pressure achieved when blowing through the EMST-150

Time frame
Baseline and 6-8 weeks
4

Change in velopharyngeal flutter following 6-8 weeks of exercises compared with baseline

Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150

Time frame
Baseline and 6-8 weeks

Secondary outcomes

1

Change in VELO questionnaire scores following 6-8 weeks of exercises compared with baseline

Percent change in Velopharyngeal Insufficiency (VPI) Effects on Life Outcomes (VELO) scores. Scores range from 0 - 100, with 100 representing the highest QOL

Time frame
Baseline and 6-8 weeks
2

Resolution of type B tympanogram following 6-8 weeks of exercises compared with baseline.

Percentage of participants with a change in tympanogram type from type B (flat) to type A (normal middle ear function).

Time frame
Baseline and 6-8 weeks
3

Resolution of type C tympanogram following 6-8 weeks of exercises compared with baseline.

Percentage of participants with a change in tympanogram type from type C (negative pressure) to type A (normal middle ear function).

Time frame
Baseline and 6-8 weeks
4

Resolution of effusion following 6-8 weeks of exercises compared with baseline.

Percentage of participants with resolution of middle ear effusion based on otoscopy.

Time frame
Baseline and 6-8 weeks

Other outcomes

1

Change in nasalance scores after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

Percent change in nasalance measured during nasometry

Time frame
6-8 weeks and 8 months
2

Change in perceptual speech symptoms of velopharyngeal dysfunction after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

Perceptual symptoms of velopharyngeal incompetence measured using the CAPS-A-AM hypernasality score, on a scale of 0-4. 0 indicates nasality that is normal for the region, 1 (borderline/minimal) suggests a minimal or inconsistent increase in nasal resonance, 2 (mild) implies hypernasality that is evident on vowels with a high tongue posture, 3 (moderate) indicates hypernasality that is perceived across all vowels, and 4 (severe) signifies that hypernasality is evident in voiced consonants and all vowels.

Time frame
6-8 weeks and 8 months
3

Change in oral pressure after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

Percent change in pressure achieved when blowing through the EMST-150

Time frame
6-8 weeks and 8 months
4

Change in velopharyngeal flutter after 6 months of maintenance exercises compared with after the initial 6-8 weeks of exercises

Change in percentage of participants with oscillating oral pressure when blowing through the EMST-150

Time frame
6-8 weeks and 8 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Noel Jabbour

Lead sponsor

University of Pittsburgh

Sponsor institution

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator